Abstract

AbstractThe hydrogen bond in the [HDihH‐Fda]+ ion (HDih: 4,5‐dihydro‐1H‐imidazole, Fda: 1‐fluoro‐N,N‐dimethylmethaneamine) can be an ordinary single well hydrogen bond (HB) or a low barrier hydrogen bond (LBHB) depending on the orientation of the CH2F group in the Fda molecule. Both domains on the cluster's potential energy surface are well separated from each other by a 10 kcal/mol high barrier, which turns the CH2F group into a switch for the LBHB. The conformers with a LBHB are generally higher in energy than their counterparts with a standard HB, which suggests that the LBHB is not necessarily the more stable bond.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.